Tag: Healthcare industry news
Government Officials Withdraw from HIMSS Health Information Conference
Government officials set to speak at the upcoming Healthcare Information and Management Systems Society (HIMSS) meeting in Las Vegas have pulled out of the event, leaving a void in the vital health tech industry...
Mass Layoffs Expected at Health Agencies Under Trump Administration
As the sun rose over Washington, D.C., on a Friday morning, thousands of federal health care workers across public health and science agencies braced themselves for the news that would change their lives. The...
Alignment Healthcare Stays as Health Insurers Flee JPM
Alignment Healthcare Stands Strong Amidst Industry TurmoilIn the midst of the chaos at the J.P. Morgan Healthcare Conference, one company stands out - Alignment Healthcare. Amidst the absence of major health insurers at the...
Patrizia Cavazzoni Departs FDA’s Drug Center: What it Means for the Agency
Patrizia Cavazzoni’s Departure and Its Implications for the FDAPatrizia Cavazzoni, the esteemed leader of the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER), has announced her departure from the agency on...
Navigating Pharma’s Patent Cliff: Impact on Obesity Fundraising and ALS Research
Navigating Pharma's Patent Cliff: Impact on Obesity Fundraising and ALS ResearchIn the fast-paced world of biotech, the looming patent cliff is causing a stir among pharmaceutical companies, investors, and researchers alike. This critical issue...
Insurance Profits and Denials Blamed for UHC CEO Death, Poll Reveals
UnitedHealthcare CEO Brian Thompson's tragic death on December 4th has sparked a nationwide conversation about the complex web of factors that may have played a role in the shooting. A recent poll conducted by...
PhRMA Membership Dues Drop by Nearly $100 Million due to Major Drugmakers Exiting
PhRMA Membership Dues Plummet by $100 Million After Major Drugmakers ExitIn a significant blow to the Pharmaceutical Research and Manufacturers of America (PhRMA), three major pharmaceutical companies, AbbVie, AstraZeneca, and Teva, made the decision...
Centene Cancels Investor Day Event After UnitedHealthcare CEO Tragedy
Centene Shifts Investor Day Event Online Following UnitedHealthcare CEO TragedyCentene, a prominent health insurer, has made the difficult decision to transition its upcoming investor day event to a virtual format in light of recent...
Sutter Health CEO Donates to Harris in Wake of Antitrust Investigation
Sutter Health's CEO, Warner Thomas, recently made significant donations to Vice President Harris' presidential campaign and the Democratic National Committee. Despite Harris' involvement in an antitrust investigation against Sutter Health in the past, Thomas...
Roivant Sells Dermatology Spinoff to Organon in $1.2B Deal
Roivant Sciences, a prominent player in the biotech industry, has once again demonstrated its prowess in dealmaking by announcing the sale of one of its subsidiaries to pharmaceutical company Organon in a significant $1.2...
BREAKING NEWS
Reforming FDA Advisory Committee Policy for Conflict of Interest-Free Decisions
Peter J. Pitts, a distinguished figure in the realm of healthcare regulation, recently shared his insights on the critical issue of FDA Advisory Committee...
